Inventor · disambiguated record
Mike Lizarzaburu
Also filed as: LIZARZABURU MIKE · LIZARZABURU MIKE E · LIZARZABURU MIKE ELIAS
12 granted patents·3 pending applications·23 citations·filing 2002–2023
87Inventor score
Top patents by PatentIndex Score
15 records- 0191US10100063B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2016·Granted Oct 16, 2018·8 cites·12 claims
- 0286US11753369B2Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Granted Sep 12, 2023·1 cites·20 claims
- 0386US10494381B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2018·Granted Dec 3, 2019·3 cites·13 claims
- 0482US11332438B2Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Granted May 17, 2022·2 cites·23 claims
- 0581US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 0680US7572783B2Substituted benzofused heterocyclesAMGEN INC·Filed 2005·Granted Aug 11, 2009·3 cites·20 claims
- 0777US2024092731A1Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 0874US10836779B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2018·Granted Nov 17, 2020·0 cites·8 claims
- 0971US6809104B2Fused heterocyclic compoundsTULARIK INC·Filed 2002·Granted Oct 26, 2004·4 cites·38 claims
- 1059US7125885B2Fused heterocyclic compoundsAMGEN INC·Filed 2004·Granted Oct 24, 2006·0 cites·2 claims
- 1155US2023339886A1Rev-erb agonists for the treatment of th17-mediated inflammatory disordersUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 1254US2022340629A1Myosin Derived Peptides and Related Compounds with Anticoagulant ActivitiesSCRIPPS RESEARCH INST·Filed 2022·Application pending·0 cites
- 1347US8022061B2N-aryl pyrazole compounds, compositions, and methods for their useAMGEN INC·Filed 2007·Granted Sep 20, 2011·0 cites·15 claims
- 1444US11274105B2Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonistsAMGEN INC·Filed 2019·Granted Mar 15, 2022·0 cites·15 claims
- 1531US8785468B2Phenylalanine amide derivatives useful for treating insulin-related diseases and conditionsDU XIAOHUI·Filed 2010·Granted Jul 22, 2014·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Mike Lizarzaburu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →